Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology
Medtech Dive
Wed, 02/15/23 - 10:25 am
Medtech
M&A
Insulet
Bigfoot Biomedical
automated insulin delivery
diabetes
Eli Lilly strikes 2nd deal to boost affordable insulin access, this time in Bangladesh
Fierce Pharma
Mon, 02/13/23 - 10:21 am
Eli Lilly
Bangladesh
insulin
diabetes
FDA offers former biotech unicorn Intarcia a chance for a panel review
BioPharma Dive
Thu, 02/9/23 - 06:04 pm
FDA
Intarcia
diabetes
drug-eluting
ITCA 650
Bydureon
Biden to push for universal insulin price cap in State of the Union
Politico
Tue, 02/7/23 - 06:53 pm
Joe Biden
drug pricing
insulin
diabetes
Lilly reports fast sales for new diabetes drug
BioPharma Dive
Thu, 02/2/23 - 11:07 pm
Eli Lilly
Mounjaro
diabetes
Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility
Medical Marketing and Media
Tue, 01/24/23 - 06:34 pm
Eli Lilly
North Carolina
diabetes
drug manufacturing
RTP
Tandem Closes Insulin Patch Deal
Medical Devices and Diagnostics Industry
Mon, 01/23/23 - 09:47 pm
Tandem Diabetes
diabetes
AMF Medical
M&A
With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena
Fierce Pharma
Mon, 01/23/23 - 10:52 am
bexaglifozin
diabetes
FDA
Brenzavvy
type 2 diabetes
Theracos
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Endpoints
Thu, 01/19/23 - 10:20 am
Merck
nitrosamine
diabetes
Januvia
Janumet
drug manufacturing
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Endpoints
Fri, 01/13/23 - 11:10 am
Novo Nordisk
Rybelsus
semaglutide
FDA
type 2 diabetes
diabetes
California is latest state to sue drug companies over high insulin prices
Marketwatch
Thu, 01/12/23 - 09:17 pm
California
drug pricing
insulin
diabetes
legal
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
Fierce Biotech
Thu, 01/12/23 - 10:39 am
Oramed
diabetes
type 2 diabetes
clinical trials
insulin
oral insulin
ORMD-0801
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Eli Lilly
Rezvoglar
diabetes
Sanofi
Lantus
biosimilars
long-acting insulin
Mark Cuban’s next act on drug costs: Tackling insulin
NBC News
Thu, 12/22/22 - 11:02 am
Mark Cuban
Mark Cuban Cost Plus Drugs
diabetes
insulin
Pfizer advances diabetes, obesity drug hopeful into mid-stage testing
BioPharma Dive
Wed, 12/21/22 - 12:34 pm
Pfizer
diabetes
obesity
PF-07081532
Sosei Heptares
Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says
Medical Marketing and Media
Mon, 12/19/22 - 10:17 pm
Eli Lilly
diabetes
drug shortages
Mounjaro
Trulicity
Lilly Plunks Down up to $731M in GPCR Pact with Sosei
BioSpace
Fri, 12/16/22 - 10:27 am
Eli Lilly
Sosei
drug discovery
drug development
diabetes
metabolic disorders
Novo Nordisk comments on role of off-label use in Ozempic shortfall
Medical Marketing and Media
Thu, 12/15/22 - 10:56 am
Novo Nordisk
Ozempic
diabetes
off label
drug shortages
Dexcom’s Jack Leach discusses preparations for G7 launch next year
Medtech Dive
Thu, 12/15/22 - 10:48 am
DexCom
diabetes
Medtech
devices
continuous glucose monitoring
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Thu, 12/15/22 - 10:46 am
Eli Lilly
Pfizer
obesity
diabetes
orforglipron
Mounjaro
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »